Search Results - "BAYER, VALENTINA"

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry by Bayer, Valentina, Kotalczyk, Agnieszka, Kea, Bory, Teutsch, Christine, Larsen, Peter, Button, Dana, Huisman, Menno V, Lip, Gregory Y H, Olshansky, Brian

“…Background Effective stroke prevention with oral anticoagulants (OAC) is recommended for some patients with atrial fibrillation (AF). We aimed to describe OAC…”
Get full text

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world by Kozieł, Monika, Teutsch, Christine, Bayer, Valentina, Lu, Shihai, Gurusamy, Venkatesh K., Halperin, Jonathan L., Rothman, Kenneth J., Diener, Hans‐Christoph, Ma, Chang‐Sheng, Huisman, Menno V., Lip, Gregory Y. H.

“…Background Prescribing patterns for stroke prevention in atrial fibrillation (AF) patients evolved with approval of non‐Vitamin K antagonist oral…”
Get full text

Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice by Taube, Christian, Bayer, Valentina, Zehendner, Christoph Michael, Valipour, Arschang

“…Introduction Chronic obstructive pulmonary disease (COPD) is a progressive disease requiring maintenance therapy. According to the Global Initiative for…”
Get full text

Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD by Calverley, Peter M A, Rennard, Stephen I, Clerisme-Beaty, Emmanuelle, Metzdorf, Norbert, Zubek, Valentina Bayer, ZuWallack, Richard

“…Several small studies found night-time awakenings due to COPD symptoms were associated with decreased health status. In this study, night-time awakenings in…”
Get full text

Patient Factors Influencing Respiratory-Related Clinician Actions in Chronic Obstructive Pulmonary Disease Screening by Wadland, William C., MD, MS, Zubek, Valentina Bayer, PhD, Clerisme-Beaty, Emmanuelle M., MD, Ríos-Bedoya, Carlos F., MPH, ScD, Yawn, Barbara P., MD, MSc

“…Introduction The purpose of this study was to identify patient-related factors that may explain the increased likelihood of receiving a respiratory-related…”
Get full text

Systems Pathology Approach for the Prediction of Prostate Cancer Progression After Radical Prostatectomy by DONOVAN, Michael J, HAMANN, Stefan, SCARDINO, Peter T, CORDON-CARDO, Carlos, CLAYTON, Mark, KHAN, Faisal M, SAPIR, Marina, BAYER-ZUBEK, Valentina, FERNANDEZ, Gerardo, MESA-TEJADA, Ricardo, TEVEROVSKIY, Mikhail, REUTER, Victor E

“…For patients with prostate cancer treated by radical prostatectomy, no current personalized tools predict clinical failure (CF; metastasis and/or…”
Get full text

Personalized prediction of tumor response and cancer progression on prostate needle biopsy by Donovan, Michael J, Khan, Faisal M, Fernandez, Gerardo, Mesa-Tejada, Ricardo, Sapir, Marina, Zubek, Valentina Bayer, Powell, Douglas, Fogarasi, Stephen, Vengrenyuk, Yevgen, Teverovskiy, Mikhail, Segal, Mark R, Karnes, R Jeffrey, Gaffey, Thomas A, Busch, Christer, Haggman, Michael, Hlavcak, Peter, Freedland, Stephen J, Vollmer, Robin T, Albertsen, Peter, Costa, Jose, Cordon-Cardo, Carlos

“…To our knowledge in patients with prostate cancer there are no available tests except clinical variables to determine the likelihood of disease progression. We…”
Get more information

Applying Systems Based Models to Predict pT3 Prostate Cancer from the Diagnostic Needle Biopsy by Donovan, Michael Joseph, PhD, MD, Powell, Douglas A., PhD, Khan, Faisal M., MS, Zubek, Valentina Bayer, PhD, Karnes, R. Jeffrey, MD

Get full text

EFFECT OF ACUTE BRONCHODILATION ON PEAK INSPIRATORY FLOW IN PATIENTS WITH STABLE COPD by Pleasants, Roy, Shaikh, Asif, Henderson, Ashley, Bayer, Valentina, Drummond, Michael

Get full text

EXACERBATION RISK IN COPD PATIENTS BASED ON EOSINOPHIL COUNT:POST HOC ANALYSIS OF THE RANDOMIZED PRAGMATIC TRIAL, AIR-WISE, COMPARING TIOTROPIUM/OLODATEROL WITH TRIPLE THERAPY by MINA, BUSHRA A, AVERILL, FRANCIS, SHAIKH, ASIF, BAYER, VALENTINA, VOSS, FLORIAN, DRDA, KRISTIN, GONGWER, RUSSELL, KATO, BERNET, J WILLEY, VINCE

Get full text

POLYPHARMACY IN A GLOBAL COHORT OF PATIENTS TAKING ANTICOAGULANTS FOR ATRIAL FIBRILLATION: THE GLORIA-AF REGISTRY by Button, Dana, Bayer, Valentina, Olshansky, Brian, Larsen, Peter, Teutsch, Christine, Patel, Sagar, Huisman, Menno, Lip, Gregory, Kea, Bory

Get full text

ANTICOAGULATION USE VARIES BY REGION IN PATIENTS WITH RECENT DIAGNOSIS OF ATRIAL FIBRILLATION: GLORIA-AF PHASE III DATA by Kea, Bory, Bayer, Valentina, Patel, Sagar, Larsen, Peter, Button, Dana, Teutsch, Christine, Huisman, Menno, Lip, Gregory Y.H., Olshansky, Brian

Get full text

Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease by Pleasants, Roy A, Shaikh, Asif, Henderson, Ashley G, Bayer, Valentina, Drummond, M Bradley

“…Identifying factors influencing peak inspiratory flow (PIF) is essential for aerosol drug delivery in stable patients with chronic obstructive pulmonary…”
Get more information

Relative efficacy and safety of inhaled corticosteroids in patients with asthma: Systematic review and network meta-analysis by Chipps, Bradley, Taylor, Ben, Bayer, Valentina, Shaikh, Asif, Mosnaim, Giselle, Trevor, Jennifer, Rogers, Sheri, Del Aguila, Michael, Paek, Dara, Wechsler, Michael E

“…Inhaled corticosteroids (ICSs) are recommended as first-line controller medications for persistent asthma. However, guidelines on the initial ICS doses,…”
Get full text

A systems‐based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long‐term outcome in men with localized prostate cancer by Donovan, Michael J., Khan, Faisal M., Bayer‐Zubek, Valentina, Powell, Douglas, Costa, Jose, Cordon‐Cardo, Carlos

“…Study Type – Prognosis (individual cohort) Level of Evidence 2a What's known on the subject? and What does the study add? Systems models have been successfully…”
Get full text

Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population by Wallace, Anna E, Kaila, Shuchita, Bayer, Valentina, Shaikh, Asif, Shinde, Mayura U, Willey, Vincent J, Napier, Mark B, Singer, Joseph R

“…Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality and is associated with substantial economic burden. There is a lack of…”
Get full text

Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10‐year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery by Donovan, Michael J., Khan, Faisal M., Powell, Douglas, Bayer‐Zubek, Valentina, Cordon‐Cardo, Carlos, Costa, Jose, Eastham, James, Scardino, Peter

“…Study Type – Prognostic (individual cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Physicians are becoming increasingly…”
Get full text

Relative efficacy and safety of inhaled corticosteroids in patients with asthma by Chipps, Bradley, Taylor, Ben, Bayer, Valentina, Shaikh, Asif, Mosnaim, Giselle, Trevor, Jennifer, Rogers, Sheri, Del Aguila, Michael, Paek, Dara, Wechsler, Michael E.

“…Inhaled corticosteroids (ICSs) are recommended as first-line controller medications for persistent asthma. However, guidelines on the initial ICS doses,…”
Get full text

Effect on Physical Position of Peak Inspiratory Flow in Stable COPD: An Observational Study by Pleasants, Roy A, Henderson, Ashley G, Bayer, Valentina, Shaikh, Asif, Drummond, M Bradley

“…We examined the effect of physical position on peak inspiratory flow (PIF) in patients with chronic obstructive pulmonary disease (COPD) using dry-powder…”
Get full text

Comparison of models to predict clinical failure after radical prostatectomy by Eggener, Scott E., Vickers, Andrew J., Serio, Angel M., Donovan, Michael J., Khan, Faisal M., Bayer‐Zubek, Valentina, Verbel, David, Cordon‐Cardo, Carlos, Reuter, Victor E., Bianco, Fernando J., Scardino, Peter T.

“…BACKGROUND: Models are available to accurately predict biochemical disease recurrence (BCR) after radical prostatectomy (RP). Because not all patients…”
Get full text